135 related articles for article (PubMed ID: 16314412)
1. Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain.
Staelens S; Hadders MA; Vauterin S; Platteau C; De Maeyer M; Vanhoorelbeke K; Huizinga EG; Deckmyn H
J Biol Chem; 2006 Jan; 281(4):2225-31. PubMed ID: 16314412
[TBL] [Abstract][Full Text] [Related]
2. Mapping the collagen-binding site in the von Willebrand factor-A3 domain.
Romijn RA; Westein E; Bouma B; Schiphorst ME; Sixma JJ; Lenting PJ; Huizinga EG
J Biol Chem; 2003 Apr; 278(17):15035-9. PubMed ID: 12582178
[TBL] [Abstract][Full Text] [Related]
3. Identification of the collagen-binding site of the von Willebrand factor A3-domain.
Romijn RA; Bouma B; Wuyster W; Gros P; Kroon J; Sixma JJ; Huizinga EG
J Biol Chem; 2001 Mar; 276(13):9985-91. PubMed ID: 11098050
[TBL] [Abstract][Full Text] [Related]
4. Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha.
Fontayne A; De Maeyer B; De Maeyer M; Yamashita M; Matsushita T; Deckmyn H
J Biol Chem; 2007 Aug; 282(32):23517-24. PubMed ID: 17569666
[TBL] [Abstract][Full Text] [Related]
5. A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction.
Vanhoorelbeke K; Depraetere H; Romijn RA; Huizinga EG; De Maeyer M; Deckmyn H
J Biol Chem; 2003 Sep; 278(39):37815-21. PubMed ID: 12855711
[TBL] [Abstract][Full Text] [Related]
6. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
7. Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain.
Hellings M; Engelborghs Y; Deckmyn H; Vanhoorelbeke K; Schiphorst ME; Akkerman JW; De Maeyer M
Proteins; 2004 Nov; 57(3):596-601. PubMed ID: 15382239
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding.
Huizinga EG; Martijn van der Plas R; Kroon J; Sixma JJ; Gros P
Structure; 1997 Sep; 5(9):1147-56. PubMed ID: 9331419
[TBL] [Abstract][Full Text] [Related]
9. Computer prediction of paratope on antithrombotic antibody 10B12 and epitope on platelet glycoprotein VI via molecular dynamics simulation.
Liu W; Liu G; Zhou H; Fang X; Fang Y; Wu J
Biomed Eng Online; 2016 Dec; 15(Suppl 2):152. PubMed ID: 28155721
[TBL] [Abstract][Full Text] [Related]
10. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.
Deckmyn H; Cauwenberghs N; Wu D; Depraetere H; Vanhoorelbeke K
Verh K Acad Geneeskd Belg; 2005; 67(1):55-65. PubMed ID: 15828307
[TBL] [Abstract][Full Text] [Related]
11. Mapping paratope on antithrombotic antibody 6B4 to epitope on platelet glycoprotein Ibalpha via molecular dynamic simulations.
Fang X; Fang Y; Liu L; Liu G; Wu J
PLoS One; 2012; 7(7):e42263. PubMed ID: 22860101
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.
Wu D; Vanhoorelbeke K; Cauwenberghs N; Meiring M; Depraetere H; Kotze HF; Deckmyn H
Blood; 2002 May; 99(10):3623-8. PubMed ID: 11986216
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies identify residues 199-216 of the integrin alpha2 vWFA domain as a functionally important region within alpha2beta1.
Tuckwell DS; Smith L; Korda M; Askari JA; Santoso S; Barnes MJ; Farndale RW; Humphries MJ
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):485-93. PubMed ID: 10947963
[TBL] [Abstract][Full Text] [Related]
14. Localization of von willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis.
Matsushita T; Meyer D; Sadler JE
J Biol Chem; 2000 Apr; 275(15):11044-9. PubMed ID: 10753907
[TBL] [Abstract][Full Text] [Related]
15. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of a human monoclonal antibody that interacts with a sulfated tyrosine-containing epitope of the GPIb receptor and inhibits platelet functions.
Hagay Y; Lahav J; Levanon A; Varon D; Brill A; Panet A
Mol Immunol; 2006 Feb; 43(5):443-53. PubMed ID: 16337487
[TBL] [Abstract][Full Text] [Related]
17. The von willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif.
Bienkowska J; Cruz M; Atiemo A; Handin R; Liddington R
J Biol Chem; 1997 Oct; 272(40):25162-7. PubMed ID: 9312128
[TBL] [Abstract][Full Text] [Related]
18. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
[TBL] [Abstract][Full Text] [Related]
19. Multiple epitope specificity of monoclonal antibodies to a single synthetic peptide: use in the characterization of the GP IIb-IIIa binding domain of von Willebrand factor.
Berliner SA; Houghten RA; Roberts JR; Ruggeri ZM
Adv Exp Med Biol; 1990; 281():133-44. PubMed ID: 1715119
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor binds to native collagen VI primarily via its A1 domain.
Hoylaerts MF; Yamamoto H; Nuyts K; Vreys I; Deckmyn H; Vermylen J
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):185-91. PubMed ID: 9164855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
